INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.

$6.07  -0.09 (-1.46%)
As of 08/05/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  
IPO date:  07/25/2017
Outstanding shares:  45,397,070
Average volume:  17,519
Market cap:   $279,645,951
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   68.34
PB ratio:   0.62
PS ratio:   4.25
Return on equity:   0.91%
Net income %:   1.86%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy